PROCEPT BioRobotics
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, PROCEPT BioRobotics sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
PROCEPT BioRobotics: 6 sponsored US clinical trials, 1 recruiting.
PROCEPT BioRobotics sponsors 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is Localized Prostate Cancer, with 3 trials.
Upper-quartile sponsor footprint
PROCEPT BioRobotics sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
WATER IV Prostate Cancer
NCT06651632
PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System
NCT06054867
PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs
NCT06051942
WATER IV PCa (AS Sub-study)
NCT07650448
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II
NCT03123250
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
NCT02505919
Therapeutic Areas
What is open in the PROCEPT BioRobotics pipeline
1 recruiting of 6 indexed (17% open); 2 completed (33%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Localized Prostate Cancer (3 trials), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
PROCEPT BioRobotics: open-pipeline peers nationwide
Peers matched on 6 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
PROCEPT BioRobotics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Adagene · 17% recruiting · 6 trials
- Agendia · 17% recruiting · 6 trials
- Akamis Bio · 17% recruiting · 6 trials
- Angiodynamics · 17% recruiting · 12 trials
Related
What to do with this PROCEPT BioRobotics page
6 registered trials is a research-attention snapshot, not an endorsement of PROCEPT BioRobotics or any single study.
- 1 of PROCEPT BioRobotics's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Localized Prostate Cancer is the condition PROCEPT BioRobotics studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Localized Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
PROCEPT BioRobotics pipeline card: 6 registered trials from official public datasets.Report a data error.